# YPrime

> YPrime provides configurable clinical trial software and services for pharmaceutical sponsors, biotechnology companies and contract research organizations. Its eCOA, IRT and eConsent products handle outcome assessments, randomization, drug supply and informed consent, supported by implementation expertise, integrations and global support.

- **Founded:** 2006
- **Headquarters:** Malvern, United States
- **Founders:** Shawn Blackburn (Co-founder and board member), Jaime Cook (Co-founder; identified by CB Insights as Executive VP / Co-Founder)
- **Products:** eCOA, IRT, eConsent, Participant Hub, AI-powered Calculation Engine
- **Notable:** Named a Leader in Everest Group’s 2025 eCOA PEAK Matrix assessment., Recognized as a Trailblazer in Patient Engagement by Everest Group in 2024., Reported inclusion in Everest Group Top 50 Pharmaceutical Technology Providers in August 2026.

## Products & services

- **eCOA** — Configurable electronic clinical outcome assessment with participant apps, a site portal, reporting, connected-device integration and localized experiences.
- **IRT** — Interactive response technology for randomization, enrollment and clinical supply management, including protocol amendments and system integrations.
- **eConsent** — Electronic informed consent integrated with the participant app, supporting comprehension and site workflows.
- **Participant Hub** — In-app For You page with study education, visit information, task priorities and approved support materials.
- **AI-powered Calculation Engine** — Natural-language configuration of structured, traceable study calculation models inside eCOA Builder.
- **Clinical trial consulting and integration** — Protocol-to-technology planning, implementation, data standards and integration support.

## Achievements

- Named a Leader in Everest Group’s 2025 eCOA PEAK Matrix assessment.
- Recognized as a Trailblazer in Patient Engagement by Everest Group in 2024.
- Reported inclusion in Everest Group Top 50 Pharmaceutical Technology Providers in August 2026.
- Reported EcoVadis Silver medal in February 2026.
- Company comparison of 15 studies across 11 languages reported 74% fewer text migration errors and a 67% shorter localization review process.

## Latest updates

- **2026-08** — Announced inclusion in Everest Group Top 50 Pharmaceutical Technology Providers.
- **2026-04** — Launched AI-powered eCOA Calculation Engine on April 28.
- **2026-04** — Launched eCOA Participant Hub on April 7.
- **2026-02** — Announced EcoVadis Silver medal.
- **2025-11** — Released research comparing AI-supported and human-led localized text migration.

## Links

- Website: https://www.yprime.com/
- LinkedIn: https://www.linkedin.com/company/y-prime/
- Twitter/X: https://twitter.com/y_prime
- Facebook: https://www.facebook.com/YPrimeFB/

---

Profile page: https://yespress.io/yprime
Published by YesPress — https://yespress.io
Last updated: 2026-10-01